chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right arm went totally dead; Speech started to become flared; Dizziness; She felt funny and slipped from the bed to the floor; Nausea; This spontaneous case was reported by a non-health professional and describes the occurrence of MONOPLEGIA (Right arm went totally dead) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MONOPLEGIA (Right arm went totally dead) (seriousness criterion medically significant), SPEECH DISORDER (Speech started to become flared), DIZZINESS (Dizziness), FALL (She felt funny and slipped from the bed to the floor) and NAUSEA (Nausea). On 22-Jan-2021, NAUSEA (Nausea) had resolved. At the time of the report, MONOPLEGIA (Right arm went totally dead), SPEECH DISORDER (Speech started to become flared), DIZZINESS (Dizziness) and FALL (She felt funny and slipped from the bed to the floor) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported.  Treatment information was not provided.  Company Comment: This case concerns a 83-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the unlisted events of dizziness, arm went totally dead/ monoplegia, speech disorder, fall, and the listed event of nausea, approximately 9 days after administration of the first dose of mRNA-1273 (Lot number: not provided) for prophylaxis of COVID-19 infection. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: Upon internal review on 16-Sep-2022, non-significant correction was performed to update case received from field.; Sender's Comments: This case concerns a 83-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the unlisted events of dizziness, arm went totally dead/ monoplegia, speech disorder, fall, and the listed event of nausea, approximately 9 days after administration of the first dose of mRNA-1273 (Lot number: not provided) for prophylaxis of COVID-19 infection. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Individual received the first 2 Pfizer doses in the series on 7/27/21 and 8/17/21.  He was administered the Moderna Booster dose of 0.25mL on 11/16/21. Individual was observed for the initial 15 minutes following the incident with vital signs obtained.  No ill effects were noted.  Follow-up with individual on 11/17/21 indicated he was only experiencing some soreness from the injection.
p/vax pt exp swelling of the lips & felt voice changed;lt side of neck became red blotchy;took DPH;
light headache; This is a spontaneous report from a contactable consumer (the patient) from a Pfizer-sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose and had a light headache. He would like to know if he can take paracetamol (TYLENOL). The outcome of light headache was unknown.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On October 6th 2006 she went to school and came home fine, by the evening of 10/06/06. She was running a fever. Her highest temperature was 103.9 - 104.0. We went to the doctor on 10/8/06 and 10/9/06 they told me to give her baths and Motrin to treat the fever. It finally stopped by Wednesday/Thursaday.
Patient received injection on 10/17/18 - The next day developed severe cramps in neck and shoulders that lasted for 5 days. Required MD office visit.
My hair started to noticeably thin after the second shot. Is now much worse and is not stopping.; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 12Nov2021 at 12:00 (Lot number: unknown) at the age of 63 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Sulfonamide allergy" (unspecified if ongoing), notes: Known allergies: Sulfa drugs. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN), administration date: 22Oct2021, when the patient was 63 years old, for COVID-19 immunisation.  The following information was reported: ALOPECIA (non-serious) with onset 19Nov2021, outcome "not recovered", described as "My hair started to noticeably thin after the second shot. Is now much worse and is not stopping". Therapeutic measures were not taken as a result of alopecia.  Additional Information: The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
pt recvd vax 1OCT94 & 11OCT94 onset of sx dark brown mass passed while urinating-no dysuria; testicular swelling; 11OCT94 pt to urologist-also had flu-like sxs; taking Cipro for 30 days;
Following vaccine pt. unable to raise her left arm. Saw medical provider 01/24/14 and given MEDROL dose pak to relieve inflammation.
When I went for 2nd dose  Medical Facility), my blood pressure was  higher than they preferred, so I didn't get it. Now, it's been 6 weeks since 1st shot; my blood pressure was higher than they preferred; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (When I went for 2nd dose ( Medical Facility), my blood pressure was  higher than they preferred, so I didn't get it. Now, it's been 6 weeks since 1st shot) and BLOOD PRESSURE INCREASED (my blood pressure was higher than they preferred) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (When I went for 2nd dose  (Medical Facility), my blood pressure was  higher than they preferred, so I didn't get it. Now, it's been 6 weeks since 1st shot) and BLOOD PRESSURE INCREASED (my blood pressure was higher than they preferred). At the time of the report, PRODUCT DOSE OMISSION ISSUE (When I went for 2nd dose (Medical Facility), my blood pressure was  higher than they preferred, so I didn't get it. Now, it's been 6 weeks since 1st shot) had resolved and BLOOD PRESSURE INCREASED (my blood pressure was higher than they preferred) outcome was unknown.
SORE ARM; FEVER AT NIGHT; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm, and fever at night. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm and fever at night was not reported. This report was non-serious.
Tested Positive for Covid 04/13/2022, 04/18/2022, 05/18/2022    Died 05/22/2022
Patient received #1 dose Pfizer Covid vaccine on 5/21/2021 and inadvertently received #2 dose of Moderna Covid vaccine today.
Severe paresthesias in face, tongue, chest wall, limbs; Tremors; Headaches; Weakness/incapacitated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "Severe paresthesias in face, tongue, chest wall, limbs"; TREMOR (non-serious), outcome "unknown", described as "Tremors"; HEADACHE (non-serious), outcome "unknown", described as "Headaches"; ASTHENIA (non-serious), outcome "unknown", described as "Weakness/incapacitated".  Additional information: It was reported that, patient for the past 9 weeks had severe paraesthesia in face, tongue, chest wall, limbs; headaches, tremors, weakness; and patient was incapacitated. Patient had a consult with the neurology department-they are seeing many people with similar reactions and believe it was similar to what the long haul covid patients have. Caller stated that, they believe she may recover slowly but it might takes months or a year.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Started as a headache and became prolonged became nauseous last about 45 days. Wife finally took me to ER.
This spontaneous case reported by a non-health professional, describes the occurrence of immunization reaction (bad side effects from two of the shots) in an adult female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 prophylaxis. No medical history information reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form.  On an unknown date, patient experienced immunization reaction (bad side effects from two of the shots). At the time of the report, immunization reaction (bad side effects from two of the shots) outcome unknown. No concomitant medication or treatment information reported.
Inconsolable crying, excessive sleeping and refusing to breastfeed for 48 hours.
1/22/2021: chills lasting 3 hours, right arm pain lasting 12 hours, fatigue lasting 12 hours.  Axillary pain and tenderness beginning 1/22/2021 and still present today 2/5/2021. It is mild to moderate but doesn?t affect my ability to perform daily activities. Worse in morning after sleep.  Still faint red patch at site of injection.
p/vax exp hive appeared about inj site;given DPH kept in office now sleeping-hive has diminished;
Client was given Pfizer Monovalent instead of a Bivalent Booster. Client waited for 30 mins self-monitored in waiting area. Reported no symptoms. Client was called on 1/5/23 at 1106. Explained the error. Client reported no symptoms other than initial soreness that was relieved in the arm after 24-48 hours. Client educated on Monovalent versus Bivalent, offered Bivalent 8 weeks since date. Client states no other needs or concerns at this time.
SkinRash & Rash Narrative: The employee was sent to the ER c/o of having a local reaction to her initial Pfizer Covid vaccination. Reaction to her left deltoid localized skin rash. She denies shortness of breath, chest pain, or palpitation. Employee's vital signs stable. Per ER physician employee advised to take oral antihistamines (Benadryl, Claritin) as directed and to take ibuprofen 400mg q. 8 hrs. as needed for local discomfort and body aches. The employee was discharged home in stable condition.
Fever 101/achy feeling all over 940AM on 16MAY91 APAP q4hrs rest/dress comfortable per v/o MD;
Patient received the vaccine right below the desired deltoid location. Site is red, swollen, painful. Patient reports flu like symptoms.
approximately 4 hours after getting vaccine on Dec 29, 2021 I had a bad cramp in left ball/toes of left foot, got it to go away and immediately had the same in right foot and just as I got to go away both feet cramped up and pretty much stayed that way for at least 3 hours when I went to bed.  Along with this was a severe increase/flare up of neuropathy in both legs and this lasted through the following day Dec 30, 2021 and went away after the next nights sleep with my CIPN being back on Dec 31, 2021 to where it was before the vaccine..
SORE ARM FOR A FEW DAYS; This spontaneous report received from a patient via a company representative concerned a 72 year old male. The patient's height, and weight were not reported. The patient's past medical history included: prostate cancer (prostate removed), and prostate removed, and concurrent conditions included: raynaud's syndrome, diverticulosis, and prediabetes, and other pre-existing medical conditions included: The patient received pneumonia vaccines and shingles vaccines (unspecified dates). The patient did not have covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Age at time of vaccination 8 decade old. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Concomitant medications included influenza vaccine for prophylactic vaccination. On an unspecified date, the patient experienced sore arm for a few days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm for a few days. This report was non-serious. This case, from the same reporter is linked to 20221260594.
>42 days of not getting the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (>42 days of not getting the second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (>42 days of not getting the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (>42 days of not getting the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment information provided.
This spontaneous social media report was received from a patient's parent via web page and refers to a female patient of unknown age. The patient's medical history and current conditions were not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL (lot #, expiration date, dose and route of administration were not reported). Secondary suspects and concomitant therapies were not reported. On an unknown date, the patient was diagnosed with co-infector and Lyme illiterate state. The patient was refused a standard anti-biotic treatment. There was some "permed ant damage" from going years without treatment. The patient underwent alternative, non-invasive treatment. The outcome of adverse events was reported as drastic improvement as the patient went from asking for a wheelchair to applying to college within days. The relatedness between adverse events and GARDASIL was not reported. Upon internal review, the events were considered to be disabling as the reporter stated that they caused permanent damage. This is one of several reports received from the same source. Additional information has been requested.
rash to neck area, took benadryl 50mg, symptoms resolved within 24 hours
I WAS 27 WEEKS PREGNANT WHEN I GOT MY SECOND DOSE OF VACCINE. ON THE SAME DAY I WAS FEELING VERY TIRED AND HAD TO REST. THEN AT ABOUT 4:00AM I GOT FEVER AND IT STAUED FOR 2 DAYS. I TOOK TYLENOL 3 TIMES A DAY.   AFTER THAT FEVER WAS COMING AND GOING EVERY OTHER DAY AND ON 04/23/2020 MY FEVER WENT UP TO 103 NAD I HAD TO RUSH TO THE ER AND THEY ADMITTED ME IMMIDIATLY AS BABY'S HEARTBEATS WENT UP TO 220.   AFTER ALL TEST DR. FOUND OUT THAT I HAD KIDNY INFACTION AND THEY KEPT ME AT THE HOSPITAL TILL 04/26/2020. SINCE THEN I AM FEELING GOOD BUT I AM STILL ON MADICATION.
Case number PHEH2014US025061, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 60 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 29 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion.
The pt has a history of multiple sclerosis and is taking Beta interferon. She was vaccinated with hepatitis A vaccine and given immune globulin for possible hepatitis A exposure in a child care center, three days later she developed left hand, leg and lower back numbness and left leg weakness.
starting to pass out; shortness of breath; gurgling sounds in her throat; This case was reported by a pharmacist via sales rep and described the occurrence of passed out in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than an hour after receiving Shingrix, the patient experienced passed out (serious criteria GSK medically significant), shortness of breath and throat discomfort. The patient was treated with epinephrine. On an unknown date, the outcome of the passed out and throat discomfort were unknown and the outcome of the shortness of breath was recovered/resolved.   It was unknown if the reporter considered the passed out, shortness of breath and throat discomfort to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was reported. In 2018, about a year, the patient received 1st dose of Shingrix and within a few minutes after receiving her vaccine, she developed shortness of breath and gurgling sounds in her throat. The pharmacist who administer vaccine to the patient was holding her up as she was starting to pass out, and called for help from another pharmacist nearby. The patient was administered epinephrine and she came back around quickly.  The reporter still called the emergency Medical Technician (EMTs) to come check her out and transport her.  The reporter eported this already to the CDC, and they are pretty sure they told GSK also.
The morning after the vaccine I woke up with a fever of about 104. I had severe chills to where my body was shaking violently and body aches. I took Tylenol. It did not help with the fever but helped a little for the body aches. For the next 5-6 days I was running fevers of 102-105.9. The only thing that would help the fevers was a lukewarm bath. Around the 4th day I called my physician and they told me my fever was too dangerous for me to go to the emergency. That day my fever broke. The chills and body aches were mild and they last about 2 weeks.
Pt woke up with a rash and hardness of upper arm, about 3-4 inch wide, area was hard and hot. Pt iced the area and took ibuprofen and Benadryl. The following day (day 2) the area is the size of an orange and red. Developing blister in center and little bisters around it.
PATIENT GOT A BOOSTER PFIZER VACCINE THAT WAS OUT OF TEMPERATURE  RANGE
severe abdominal pain; headache; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 20Apr2021 09:15 (Lot number: EW0169) at the age of 33 years as dose 1, single for covid-19 immunization. The patient's relevant medical history was none, and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN (non-serious) with onset 04May2021 09:00, outcome "recovering", described as "severe abdominal pain"; HEADACHE (non-serious) with onset 04May2021 09:00, outcome "recovering", described as "headache". The events "severe abdominal pain" and "headache" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of abdominal pain, headache.  Additional information: The patient 2 weeks after the first dose experienced severe abdominal pain, headache. Therefore, went to the emergency room 4 times, blood work and CT scan were good. Still don't know the nature of that pain. The patient neither received other vaccines within 4 weeks prior to the COVID vaccine nor received any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies. covid test post vaccination (Nasal Swab) on 30May2021 resulted negative. The device date was 30May2021.  Follow-up attempts are completed. No further information is expected.
Patient's elbow swelled up in the arm he received the vaccine in/was very swollen painful, and warm; Patient's elbow swelled up in the arm he received the vaccine in/was very swollen painful, and warm; Patient's elbow swelled up in the arm he received the vaccine in/was very swollen painful, and warm; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date in the arm at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced patient's elbow swelled up in the arm he received the vaccine in/was very swollen painful, and warm on an unspecified date. The events took place after use of product. The outcome of the events was recovered on an unspecified date.  Information on the lot/batch number has been requested.
Chest Pain, Heart Palpitations Waking from Sleep, Shortness Breath, tight jaw, Indigestion, Nausea, Short of Breath.
Uncontrollable vomiting, syncope and collapse few hours after receiving influenza and Tdap vaccination.  Pt went to ED for treatment.
(R) lateral thigh - swollen & red x 1 day measuring 4-5 cm.
Patient reported having symptoms of low blood sugar after both Pfizer covid shots. Reported shakiness. When blood glucose was tested had a number in the 80s and 90s.
Swollen  glands in face and neck for entire time since shot.    whole body rash and itchiness that has become worse over time
occurred 2-0 minutes after the injection- tingling tongue and facial numbness for the nose down to the chin. Sypmtoms are still present 7-13-22
Reporter states a number of c/o reagrding intensity of local reacts w/1 lot# during a 1 mo period JUN93; pt dx'd w/presumed cellulitis @ inject site 3 days p/vax; rx'd w/ATB;
Immediately after receiving vaccine, patient started to have a racing heart beat, felt like it was skipping beats.  Heart was elevated to 115.  Patient was given water, an EKG was performed, Heart rate lowered to 75